Company Filing History:
Years Active: 2022
Title: Calvin McCarter: Innovator in Cancer Classification Technologies
Introduction
Calvin McCarter is a notable inventor based in Chicago, IL, who has made significant contributions to the field of cancer diagnostics. His innovative work focuses on systems and methods for multi-label cancer classification, which aims to enhance the accuracy of cancer diagnoses.
Latest Patents
Calvin McCarter holds a patent for "Systems and methods for multi-label cancer classification." This patent describes a method that receives sequencing information derived from a somatic tumor specimen. The method identifies various features from the sequencing data, including RNA, DNA, RNA splicing, viral, and copy number features. It utilizes multiple classifiers to generate predictions regarding the cancer condition and combines these predictions to provide a comprehensive diagnosis.
Career Highlights
Calvin is currently employed at Tempus Labs, Inc., where he applies his expertise in cancer classification technologies. His work is pivotal in advancing the capabilities of cancer diagnostics, ultimately aiming to improve patient outcomes through more accurate identification of cancer conditions.
Collaborations
Calvin collaborates with talented individuals such as Jackson Michuda and Kyle Ashley Beauchamp, contributing to a dynamic team focused on innovative solutions in healthcare.
Conclusion
Calvin McCarter's contributions to cancer classification technologies exemplify the impact of innovation in the medical field. His work not only enhances diagnostic accuracy but also plays a crucial role in the ongoing fight against cancer.